お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
979929

コンパニオン診断の世界市場(2020年~2024年)

Global Companion Diagnostics Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.93円
コンパニオン診断の世界市場(2020年~2024年)
出版日: 2020年12月23日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

コンパニオン診断の市場規模は、2020年~2024年の予測期間中に26%のCAGRで成長し、57億4,000万米ドル成長すると予測されています。コンパニオン診断市場に関する当レポートは、全体的な分析、市場規模と予測、動向、成長要因、および課題、ならびに約25のベンダーをカバーするベンダー分析を提供します。

市場は、個別化医療の使用の増加、業界のコラボレーションの増加、およびライフサイエンスセクターへの投資の増加によって推進されています。さらに、個別化医療の使用の増加は、市場の成長も後押しすると予想されます。

当レポートではコンパニオン診断の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、エンドユーザー別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模(2019年)
  • 市場の見通し(2019年~2024年)

ファイブフォース分析

エンドユーザー別

  • 市場セグメンテーション
  • エンドユーザー別比較
  • ライフサイエンス
  • ヘルスセンター
  • その他
  • エンドユーザー別市場機会

顧客情勢

地域別

  • 地域別セグメンテーション
  • 地域別比較
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 地域の市場機会
  • ボリューム成長要因-需要主導の成長
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR46416

Technavio has been monitoring the companion diagnostics market and it is poised to grow by $ 5.74 bn during 2020-2024 progressing at a CAGR of 26% during the forecast period. Our report on companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector. In addition, rising use of personalized medicine is anticipated to boost the growth of the market as well.

The companion diagnostics market analysis includes end-user segment and geographical landscapes.

Technavio's companion diagnostics market is segmented as below:

By End-user

  • Life science
  • Health centers
  • Others

By Geographic Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on companion diagnostics market covers the following areas:

  • Companion diagnostics market sizing
  • Companion diagnostics market forecast
  • Companion diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Life science - Market size and forecast 2019-2024
  • Health centers - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by End-user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: End user - Market share 2019-2024 (%)
  • 22: Comparison by End user
  • 23: Life science - Market size and forecast 2019-2024 ($ million)
  • 24: Life science - Year-over-year growth 2019-2024 (%)
  • 25: Health centers - Market size and forecast 2019-2024 ($ million)
  • 26: Health centers - Year-over-year growth 2019-2024 (%)
  • 27: Others - Market size and forecast 2019-2024 ($ million)
  • 28: Others - Year-over-year growth 2019-2024 (%)
  • 29: Market opportunity by End user
  • 30: Customer landscape
  • 31: Market share by geography 2019-2024 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: Europe - Market size and forecast 2019-2024 ($ million)
  • 36: Europe - Year-over-year growth 2019-2024 (%)
  • 37: Asia - Market size and forecast 2019-2024 ($ million)
  • 38: Asia - Year-over-year growth 2019-2024 (%)
  • 39: ROW - Market size and forecast 2019-2024 ($ million)
  • 40: ROW - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Abbott Laboratories - Overview
  • 50: Abbott Laboratories - Business segments
  • 51: Abbott Laboratories - Key offerings
  • 52: Abbott Laboratories - Key customers
  • 53: Abbott Laboratories - Segment focus
  • 54: Agilent Technologies Inc. - Overview
  • 55: Agilent Technologies Inc. - Business segments
  • 56: Agilent Technologies Inc. - Key offerings
  • 57: Agilent Technologies Inc. - Key customers
  • 58: Agilent Technologies Inc. - Segment focus
  • 59: bioMerieux SA - Overview
  • 60: bioMerieux SA - Business segments
  • 61: bioMerieux SA - Key offerings
  • 62: bioMerieux SA - Key customers
  • 63: bioMerieux SA - Segment focus
  • 64: F. Hoffmann-La Roche Ltd. - Overview
  • 65: F. Hoffmann-La Roche Ltd. - Business segments
  • 66: F. Hoffmann-La Roche Ltd. - Key offerings
  • 67: F. Hoffmann-La Roche Ltd. - Key customers
  • 68: F. Hoffmann-La Roche Ltd. - Segment focus
  • 69: Illumina Inc. - Overview
  • 70: Illumina Inc. - Product and service
  • 71: Illumina Inc. - Key offerings
  • 72: Illumina Inc. - Key customers
  • 73: Illumina Inc. - Segment focus
  • 74: Myriad Genetics Inc. - Overview
  • 75: Myriad Genetics Inc. - Business segments
  • 76: Myriad Genetics Inc. - Key offerings
  • 77: Myriad Genetics Inc. - Key customers
  • 78: Myriad Genetics Inc. - Segment focus
  • 79: QIAGEN NV - Overview
  • 80: QIAGEN NV - Business segments
  • 81: QIAGEN NV - Key offerings
  • 82: QIAGEN NV - Key customers
  • 83: QIAGEN NV - Segment focus
  • 84: Siemens Healthineers AG - Overview
  • 85: Siemens Healthineers AG - Business segments
  • 86: Siemens Healthineers AG - Key offerings
  • 87: Siemens Healthineers AG - Key customers
  • 88: Siemens Healthineers AG - Segment focus
  • 89: Sysmex Corp. - Overview
  • 90: Sysmex Corp. - Product and service
  • 91: Sysmex Corp. - Key offerings
  • 92: Sysmex Corp. - Key customers
  • 93: Sysmex Corp. - Segment focus
  • 94: Thermo Fisher Scientific Inc. - Overview
  • 95: Thermo Fisher Scientific Inc. - Business segments
  • 96: Thermo Fisher Scientific Inc. - Key offerings
  • 97: Thermo Fisher Scientific Inc. - Key customers
  • 98: Thermo Fisher Scientific Inc. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.